trending Market Intelligence /marketintelligence/en/news-insights/trending/ea0bscfh5mgthm10c6q4sq2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

OncoCyte names COO


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

OncoCyte names COO

Alameda, Calif.-based OncoCyte Corp. appointed Albert Parker as COO.

Previously, Parker served as the managing shareholder of GC Legal Advisors. He has also served as executive vice president, general counsel and corporate secretary at Sunovion Pharmaceuticals Inc.

OncoCyte is a biotechnology company and focuses on developing non-invasive blood and urine diagnostic tests for the early detection of cancer.